World Vaccine Hoarding Could Make The Pandemic Drag on an Extra 7 Years
The growing evidence that the Covid-19 vaccines can reduce transmission, explained
Here’s what we know about how the vaccines protect against spread of the virus.Despite that fact, public health officials and media outlets have been warning that vaccinated people need to behave largely how they did before they were vaccinated. That’s because we don’t know as much about the vaccines’ effectiveness at preventing transmission to others.
We all desperately want this global pandemic to end, but that won't happen for many more years if the wealthiest nations don't share their vaccines with the rest of the world, argue health experts.
By mid-February 2021, 191 million vaccination shots had been administered, and more than three quarters of those were received in just 10 countries,.
In contrast, by that same time, roughly 130 nations, which together include 2.5 billion people, had been given no shots at all. Not a single one.
Are White 'Vaccine Chasers' the Reason People of Color Aren't Getting Their COVID-19 Shots?
Black and brown Los Angeles, California, residents—who are most likely to die from the coronavirus—are being vaccinated at low rates despite efforts to reach them.Veronica Sance was irate. For days, she'd been monitoring the sidewalk in front of a prime South Los Angeles COVID-19 vaccination site, Kedren Community Health Center. And she did not like what she was seeing.
Public health expert Gavin Yamey is the latest to join aof other calling upon rich nations to stop 'hoarding' COVID-19 vaccines.
In a recent Nature, the Duke University professor uses game theory to explain why 'vaccine nationalism' is ultimately selfish and self-defeating.
If the richest in the world continue to hoard vaccines, he argues, the global pandemic may potentially drag on for as long as seven more years.
"There's a mantra in global health that an outbreak anywhere could lead to an outbreak everywhere, and that's why it's in our interest collectively as an international community to start sharing doses (and) to make sure we expand the global vaccine supply," Yameyin a media briefing on his Nature commentary.
How the Johnson & Johnson single-dose COVID-19 vaccine is different from others
There is a new vaccine approved in the United States and it has one major difference which is hoped to speed up the immunisation of the country.The US Food and Drug Administration (USFDA) cleared the vaccine produced by medical giant Johnson & Johnson.
A few days after the commentary was published, it was revealed thatof the AstraZeneca vaccine to Australia due to ongoing frustrations over supply shortages in the European Union.
Buying vaccines does not have to be a, Yamey and his colleagues have .
Instead, there are ways we can guarantee equitable access to COVID-19 vaccines worldwide while still investing in doses. Agreements between manufacturers and wealthy nations, for instance, could simultaneously help expand global supplies and manufacturing elsewhere in the world.
"As nations, we are like ships on an ocean," Yamey, "and we're going to rise and fall together."
Yamey points to the new COVID-19 Vaccines Global Access Facility (COVAX) as a good example of how to keep us all afloat in these unprecedented times.
The program, co-led by Gavi, the Vaccine Alliance; the Coalition for Epidemic Preparedness Innovations; and the World Health Organization (WHO), creates a 'buyers' pool in which wealthier nations can purchase vaccines in a way that ensures supply and development to poorer places.
The key ingredient that could hold back vaccine manufacturing
You may not have heard of them, but lipid nanoparticles are key to the Moderna and Pfizer vaccines.Here’s part of the answer: We’re still racing to make a special type of lipid, a relatively unknown but critical component of the vaccines being manufactured by Moderna and Pfizer/BioNTech. These vaccines use messenger RNA, the genetic component commonly known as mRNA that instructs cells to make proteins, which in turn teach the human body how to fight the virus that causes Covid-10.
So far, around 190 nations have joined COVAX, and yet close to three dozen wealthy nations ended up buying their vaccines directly from suppliers and not through the 'buyers' pool. In the end, that means 16 percent of the world's population has bought more than half of all available doses.
The agreement between the United States Department of Health and Human Services (HHS) and Pfizer/BioNtech, for instance, is designed to benefit the US and Pfizer, ""
This "" approach represents a major threat to achieving herd immunity at a global scale, experts say. Not only will this condemn people to death and sickness merely through the luck of their birthplace, it gives the virus a chance to mutate in a way our current vaccines may not account for.
"There is no way to stop wealthier countries from pursuing these deals, but COVAX can influence how such deals are made, so that more of these deals are beneficial to the rest of the world… and not simply 'vaccine grabs' that take doses away from everyone else (like the HHS deal)," Yamey and his colleaguesin another recent commentary for BMJ Global Health.
Black, Latino Californians Given 20% Of State's COVID Vaccines, But Make Up 42% of Population
California Gov. Gavin Newsom has called equity his "North Star," but the vaccine rollout is leaving the state's largest, most vulnerable communities behind.African Americans have received 3 percent of vaccine doses while they make up 6 percent of the state, according to the Associated Press. Latinos, who make up 39 percent of the state, have received 17 percent of doses. The vaccination gap is much narrower for white Californians, who make up 36 percent of the state's population. State health data shows that 32 percent of white people in the state have already received shots.
Both these commentaries follow recent statements from the director general of WHO, Tedros Adhanom Ghebreyesus, whoin January that the world was "on the brink of a catastrophic moral failure", where only wealthy people are protected from COVID-19, at least in the short-term.
Others, like philosopher Nicole Hassoun have since"vaccine nationalism is neither ethically justified, nor even in rich countries' long term self-interest."
So what is the better option? In his new commentary, Yamey argues wealthier nations need to share their vaccines as soon as possible. For every nine doses they administer, he suggests donating one dose to COVAX. This is hardly 'equitable', he admits, but it's "" and could stop the emergence of future variants and outbreaks.
Such action could also save the world a lot of money. One recentfound if poorer nations are not vaccinated for several years, the global economy could lose US$9 trillion from a disruption in global supply chains. Rich nations would bear half that cost.
Putting basic health systems in place that improve the global supply of vaccines, enhance supply-chain harmonization and articulate guiding principles so that everyone benefits from this medicine is not just the right thing to do ethically or economically, it's also the best way to end a global pandemic for everyone.
The commentary was published in.
US experts tackle ethical dilemmas posed by the vaccine rollout .
The approval of multiple coronavirus vaccines has given people hope, but the rollout has brought uncertainty of its own. © A nurse prepares the Pfizer COVID-19 vaccine [File: Frederic J Brown/AFP] A nurse prepares the Pfizer COVID-19 vaccine [File: Frederic J Brown/AFP] In some locations, demand is greater than supply. Some people wonder why they were excluded from priority groups. Vaccine doses due to expire or leftover from cancellations and no-shows are given to people regardless of priority status instead.